Brief: Assembly Biosciences And Arbutus Biopharma Initiate Phase 2 Clinical Trial Of Triple Combination Therapy For The Treatment Of Chronic Hepatitis B Virus

Assembly Biosciences

26/02/2021 12:31

Feb 26 (Reuters) - Arbutus Biopharma Corp  ABUS.O :
    * ASSEMBLY BIOSCIENCES AND ARBUTUS BIOPHARMA INITIATE PHASE
2
CLINICAL TRIAL OF TRIPLE COMBINATION THERAPY FOR THE TREATMENT
OF CHRONIC HEPATITIS B VIRUS

Source text for Eikon:  ID:nGNX22VBDP 
Further company coverage:  ABUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))